<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Patented Medicines</title>
    <link>https://www.taxtmi.com/news?id=20901</link>
    <description>Compulsory licences are regulated by the Patents Act, 1970 and the term &quot;Mandatory Licence&quot; is not used. One compulsory licence was granted by the Controller of Patents to M/s. NATCO Pharma in respect of a pharmaceutical originator&#039;s patent for a cancer treatment drug, and compulsory licences are issued only in accordance with the Act&#039;s provisions; no specific proposal for a further compulsory licence was pending at the time of the official statement.</description>
    <language>en-us</language>
    <pubDate>Mon, 31 Dec 2018 13:09:00 +0530</pubDate>
    <lastBuildDate>Mon, 31 Dec 2018 13:09:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=550264" rel="self" type="application/rss+xml"/>
    <item>
      <title>Patented Medicines</title>
      <link>https://www.taxtmi.com/news?id=20901</link>
      <description>Compulsory licences are regulated by the Patents Act, 1970 and the term &quot;Mandatory Licence&quot; is not used. One compulsory licence was granted by the Controller of Patents to M/s. NATCO Pharma in respect of a pharmaceutical originator&#039;s patent for a cancer treatment drug, and compulsory licences are issued only in accordance with the Act&#039;s provisions; no specific proposal for a further compulsory licence was pending at the time of the official statement.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 31 Dec 2018 13:09:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=20901</guid>
    </item>
  </channel>
</rss>